Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
163,926,065
-
Total 13F shares
-
38,782
-
Share change
-
-33,165
-
Total reported value
-
$515,801
-
Price per share
-
$13.30
-
Number of holders
-
1
-
Value change
-
-$441,095
-
Number of sells
-
1
Institutional Holders of Dyne Therapeutics, Inc. - COMMON STOCK (DYN) as of Q4 2023
As of 31 Dec 2023,
Dyne Therapeutics, Inc. - COMMON STOCK (DYN) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
38,782 shares.
The largest 10 holders included
Atlas Venture Life Science Advisors, LLC, FCPM III SERVICES B.V., MPM ASSET MANAGEMENT LLC, BlackRock Inc., CITADEL ADVISORS LLC, STATE STREET CORP, VANGUARD GROUP INC, VR Adviser, LLC, Vida Ventures Advisors, LLC, and MORGAN STANLEY.
This page lists
123
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.